Lixi Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Squamous Cell Carcinoma

Positive Breast Cancer

Top Venues

Cancer innovation

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Future oncology (London, England)

Technology in cancer research & treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Lixi Li, Yun Wu, Bo Lan, Zongbi Yi
Efficacy and safety of first-line regimens for advanced HER2-positive breast cancer: A Bayesian network meta-analysis. Cancer innovation 3 (4) (2024)
Lixi Li, Yun Wu, Bo Lan, Zongbi Yi
Efficacy and safety of first-line regimens for advanced HER2-positive breast cancer: A Bayesian network meta-analysis. Cancer innovation 3 (4) (2024)
Di Zhang, Lixi Li, Zongbi Yi
Integrative analyses identified gap junction beta-2 as a prognostic biomarker and therapeutic target for breast cancer. Cancer innovation 3 (4) (2024)
Di Zhang, Lixi Li, Zongbi Yi
Integrative analyses identified gap junction beta-2 as a prognostic biomarker and therapeutic target for breast cancer. Cancer innovation 3 (4) (2024)
Di Zhang, Lixi Li
The clinical significance for primary tumor surgery in metastatic head and neck adenoid cystic carcinoma. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2023)
Di Zhang, Lixi Li
Risk factors and prognostic models of lymph node metastatic hypopharyngeal squamous cell carcinoma. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2023)
Di Zhang, Lixi Li
Lymph node ratio-based prognostic model for risk stratification and individualized adjuvant therapy for postoperative major salivary duct carcinoma. Head & neck (2023)
Hewei Ge, Lixi Li, Di Zhang, Zongbi Yi
Applications of digital Medicine in oncology: Prospects and challenges. Cancer innovation 1 (4) (2022)
Binliang Liu, Zong-Bi Yi, Yanfang Guan, Quchang Ouyang, Chunxiao Li, Xiuwen Guan, Dan Lv, Lixi Li, Jingtong Zhai, Haili Qian, Bing-He Xu, Zongbi Yi, Yixin Zeng
Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients. Cancer medicine 11 (14) (2022)
Binliang Liu, Xiuwen Guan, Yanfeng Wang, Xiaoying Sun, Zongbi Yi, Dan Lv, Wenna Wang, Lixi Li, Jingtong Zhai, Hong Li, Zongbi Yi
Clinical and genetic predictions of early-onset cardiac toxicity in adjuvant chemotherapy for breast cancer. Future oncology (London, England) 18 (17) (2022)
Lixi Li, Di Zhang, Fei Ma
Nomogram-Based Prediction of Overall and Disease-Specific Survival in Patients With Postoperative Major Salivary Gland Squamous Cell Carcinoma. Technology in cancer research & treatment 21 (2022)
Di Zhang, Lixi Li
Prognostic models for estimating survival of salivary duct carcinoma: a population-based study. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2022)